Transgenic Animal Model Market Size, Share, Trend Report 2026 to 2035

Report Id: 3508 Pages: 180 Last Updated: 24 March 2026 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Transgenic Animal Model Market Segmentation:

Transgenic Animal Model Market by Animal Type- 

• Rodent (Mice & Rats)
• Pigs
• Rabbits
• Others

Transgenic Animal Model Market seg

Transgenic Animal Model Market by Technology-

• CRISPR/CAS-9
• Embryonic Stem Cell Injections 
• Microinjections
• Others

Transgenic Animal Model Market by Application-

• Drug Discovery and Development
• Toxicology and Safety Testing
• Gene Function Studies
• Disease Research
• Others

Transgenic Animal Model Market by End-user-

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes

Transgenic Animal Model Market by  Region

North America-

• The US
• Canada

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Mexico
• Argentina
• Rest of Latin America

Middle East & Africa-

• GCC Countries
• South Africa
• Rest of Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Transgenic Animal Model Market Snapshot

Chapter 4. Global Transgenic Animal Model Market Variables, Trends & Scope

4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter’s Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2026-2035
4.8. Global Transgenic Animal Model Market Penetration & Growth Prospect Mapping (US$ Mn), 2025-2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Model development workflow & cost benchmarking
4.11. CRISPR vs traditional model efficiency comparison
4.12. Regulatory & ethical compliance landscape
4.13. Animal model demand forecasting by therapeutic area
4.14. Use/impact of AI on Transgenic Animal Model Market Industry Trends

Chapter 5. Transgenic Animal Model Market Segmentation 1: By Animal Type, Estimates & Trend Analysis

5.1. Market Share by Animal Type, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Animal Type:

5.2.1. Rodent (Mice & Rats)
5.2.2. Pigs
5.2.3. Rabbits
5.2.4. Others

Chapter 6. Transgenic Animal Model Market Segmentation 2: By Technology, Estimates & Trend Analysis

6.1. Market Share by Technology, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Technology:

6.2.1. CRISPR/CAS-9
6.2.2. Embryonic Stem Cell Injections
6.2.3. Microinjections
6.2.4. Others

Chapter 7. Transgenic Animal Model Market Segmentation 3: By Application, Estimates & Trend Analysis

7.1. Market Share by Application, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Application:

7.2.1. Drug Discovery and Development
7.2.2. Toxicology and Safety Testing
7.2.3. Gene Function Studies
7.2.4. Disease Research
7.2.5. Others

Chapter 8. Transgenic Animal Model Market Segmentation 4: By End-user, Estimates & Trend Analysis

8.1. Market Share by End-user, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following End-user:

8.2.1. Pharmaceutical & Biotechnology Companies
8.2.2. Contract Research Organizations (CROs)
8.2.3. Academic & Research Institutes

Chapter 9. Transgenic Animal Model Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. Global Transgenic Animal Model Market, Regional Snapshot 2025 & 2035
9.2. North America

9.2.1. North America Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035

9.2.1.1. US
9.2.1.2. Canada

9.2.2. North America Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2022-2035
9.2.3. North America Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022-2035
9.2.4. North America Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
9.2.5. North America Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022-2035

9.3. Europe

9.3.1. Europe Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035

9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe

9.3.2. Europe Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2022-2035
9.3.3. Europe Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022-2035
9.3.4. Europe Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
9.3.5. Europe Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035

9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific

9.4.2. Asia Pacific Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2022-2035
9.4.3. Asia Pacific Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022-2035
9.4.4. Asia Pacific Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
9.4.5. Asia Pacific Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022-2035

9.5. Latin America

9.5.1. Latin America Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035

9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America

9.5.2. Latin America Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2022-2035
9.5.3. Latin America Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022-2035
9.5.4. Latin America Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
9.5.5. Latin America Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022-2035

9.6. Middle East & Africa

9.6.1. Middle East & Africa Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2035

9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa

9.6.2. Middle East & Africa Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2022-2035
9.6.3. Middle East & Africa Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022-2035
9.6.4. Middle East & Africa Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
9.6.5. Middle East & Africa Transgenic Animal Model Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022-2035

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles

10.2.1. Charles River Laboratories International, Inc.

10.2.1.1. Business Overview
10.2.1.2. Key Product/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy

10.2.2. Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
10.2.3. Sigma-Aldrich Co. (Merck Group)
10.2.4. Ingenious Targeting Laboratory
10.2.5. OmniAb, Inc.
10.2.6. Creative Biolabs
10.2.7. Alloy Therapeutics, Inc.
10.2.8. Inotiv
10.2.9. Taconic Biosciences
10.2.10. genOway
10.2.11. HuidaGene
10.2.12. Janvier Group (Janvier Labs)
10.2.13. Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
5100
Security Code field cannot be blank!

Frequently Asked Questions

Transgenic Animal Model Market Size is valued at USD 2.75 Bn in 2025 and is predicted to reach USD 6.59 Bn by the year 2035

Transgenic Animal Model Market is expected to grow at a 9.4% CAGR during the forecast period for 2026 to 2035.

Charles River Laboratories International, Inc., Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Sigma-Aldrich Co. (Merck Group), Ingenious Targeting Laboratory, OmniAb, Inc., Creative Biolabs, Alloy Therapeutics, Inc., Inotiv, Taconic Biosciences, HuidaGene, genOway, and Janvier Group (Janvier Labs).

Transgenic Animal Model Market is segmented into Animal Type, Technology, Application, End-user, Distribution Channel, and By Region

North America region is leading the Transgenic Animal Model Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying